Paciente Neonatal

Bibliografía
1 American Society of Health-System Pharmacists. Suggested definitions and relationships
among medication misadventures, medication errors, adverse drug events, and
adverse drug reactions. Am J Health- Syst Pharm 1998; 55: 165-6.
2 Avenel S, Bomkratz A Dassieu G. et al. The incidence of prescriptions without marketing
product license in a neonatal intensive care unit. Arch Pediatr 2000; 7(2):143-7
3 Barr J, Brenner-Zada G, Heiman E. et al. Unlicensed and off-label medication use in a
neonatal intensive care unit: a prospective study. Am J Perinatol 2002; 19:67-72
4 Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in
hospitalized adults. J Gen Intern Med 1993; 8: 289-94.
5 Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG, et al. Incidence
of adverse events and negligence in hospitalized patients. Results of the Harvard
Medical Practice Study I. N Engl J Med. 1991; 324:370-6.
6 Campino A, Lopez-Herrera MC, Lopez-de-Heredia I, Valls-i-Soler A. Educational strategy
to reduce medication errors in a neonatal intensive care unit. Acta Paediatric 2009;
May 98(5):782-5.
7 Christopher S, Parshuram MB, To T, Seto W, Trope A, Koren G, Laupacis MD. CMAJ
2008; 178(1):42-8
8 Conroy S, Choonara I, Impicciatore P, et al. Unlicense and off-label drug use in pediatric
wards in different European countries. BMJ 2000; 320: 79-82
9 Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and
children in different settings: a review of the literature and a consideration about drug
safety. Expert Opin Drug Saf 2006; 5(5): 703-18.
10 Fahimi F, Ariapanah P, Faizi M, Shafaghi B, Namdar R, Ardakani MT. Errors in preparation
and administration of intravenous medications in the intensive care unit of a teaching
hospital: an observational study. Aust Crit Care. 2008; 21:110-116.
11 Graafmans W. Acciones para la seguridad del paciente en la Unión Europea. Acciones
de la Unión Europea en seguridad del paciente y calidad. VI Conferencia Internacional
de Seguridad del Paciente 19º Colloquium Cochrane Madrid, España. Ministerio de
Sanidad, Política Social e Igualdad; 19-20 de octubre 2011 Disponible en dirección web
http://www. seguridaddelpaciente.es/index.php/lang-es/informacion/eventos/conferenciasinternacionales-sp/vi-conferencia/presentaciones.html
12 Kanter DE,Turenne W, Slonim AD. Hospital-reported medical errors in premature neonates.
Pediatr Crit Care Med. 2004;5:119-123.
13 Kohn LT, Corrigan JM, Donaldson M. To err is human: building a safer health system.
Report of the Institute of Medicine. Washington, DC: National Academy Press, 1999.
14 Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al. Systems
analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995; 274:35-43.
15 Leape LL, Kabcenell A, Berwick DM, Roessner J. Breakthrough Series Guide: Reducing
adverse drug events. Boston: Institute for Healthcare Improvement, 1998.
ESTADO DE LA SEGURIDAD DEL PACIENTE NEONATAL 45